Association between Argyrophilic Proteins of Nucleolar Organizer Regions, Clinicomorphological Parameters, and Survival in Non-Small-Cell Lung Cancer

Table 1

AI AgNOR and CV AgNOR in non-small-cell lung cancer.

Parameter	Number of cases (abs. (%))	AgNOR
		AI	M-W	CV	M-W
Primary tumor
T 1	70 (29)	5.89±1.49	<0.001	29.5±4.5	0.006
T 2-3	173 (71)	6.81±1.68		31.1±4.6
Greatest dimension
<3 cm	104 (43)	5.84±1.54	<0.001	29.3±4.0	<0.001
≥3 cm	139 (57)	7.05±1.58		31.5±4.8
Lymph nodes
N 0	157 (65)	6.27±1.59	<0.001	30.3±4.5	0.1
N 1–3	86 (35)	7.06±1.70		31.2±4.8
Stage
I	139 (57)	6.23±1.62	<0.001	30.4±4.5	0.5
II-III	104 (43)	6.99±1.64		30.9±4.7
Histogenesis
Adenocarcinoma	111 (46)	6.05±1.78	<0.001	29.8±4.7	0.02
Squamous cell	132 (54)	6.96±1.46		31.2±4.4
Differentiation
High	63 (26)	5.90±1.54	<0.001	29.4±3.7	0.02
Moderate-low	180 (74)	6.76±1.66		31.0±4.8